David Jennions

David is an old-school systems' engineer, enjoying the challenges of meshing the diverse disciplines of science and engineering. He started into Lab Automation at Applied Biosystems, leading architecture for a new oligonucleotide manufacturing plant. He moved from California to Milan, to join a drug discovery CRO, Axxam SpA, to create compound storage and management systems for high-throughput screening. He then moved back to the US to coordinate organizations of scientists and engineers to build a fully-integrated platforms with applications across genetic screening with Counsyl, mass-production of CRISPR RNA with Synthego, and liquid biopsy with GRAIL - the most recent role helping detect cancer at population-scale. David has been an active member of the SLAS community since 2009, serving in various roles including journal board, membership committee, award judging, and Board member. He has a Master in Physics at Cambridge University in the UK, a Masters in Instrumentation Systems, a